ALNY
ALNYLAM PHARMACEUTICALS, INC.
NASDAQ · Healthcare · Biotechnology · US
$162.92
+1.90%Forward multiples
Based on analyst estimates
- P/E forward
- 23.17x
- P/E 2026E
- 8.80x
- P/E 2027E
- 18.08x
- P/E 2028E
- 14.25x
- P/S forward
- 3.38x
Trailing multiples
Trailing twelve months
- P/E TTM
- 7.99x
- PEG TTM
- —
- Price / book
- 6.05x
- Price / sales
- 4.35x
- Price / cash flow
- 33.55x
Enterprise value
- Enterprise value
- $19.5B
- EV / sales
- 3.89x
- EV / EBITDA
- 15.62x
- EV / EBIT
- 19.94x
- Market cap
- $21.8B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Sep 1, 2026